|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61P 7/06 | |||
| A61K 38/45 | |||
| A61K 45/06 | |||
| A61K 38/00 | |||
| C12N 9/12 |
| (11) | Patento numeris | 3520805 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19161424.7 |
| Europos patento paraiškos padavimo data | 2012-10-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161547932 P | 2011-10-17 | US |
| (72) |
SEEHRA, Jasbir, US
PEARSALL, Robert, Scott, US
KUMAR, Ravindra, US
SURAGANI, Naga, Venkata Sai Rajasekhar, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | COMPOSITIONS FOR TREATING MYELOFIBROSIS |
| COMPOSITIONS FOR TREATING MYELOFIBROSIS |